Signet Investment Advisory Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.56M Sell
4,634
-30
-0.6% -$30.7K 2.44% 16
2026
Q1
$4.29M Sell
4,664
-79
-2% -$80.1K 1.97% 20
2025
Q4
$5.1M Buy
4,743
+304
+7% +$291K 2.37% 17
2025
Q3
$3.39M Buy
4,439
+387
+10% +$288K 1.63% 25
2025
Q2
$3.16M Buy
4,052
+9
+0.2% +$6.99K 1.62% 25
2025
Q1
$3.34M Buy
4,043
+210
+5% +$175K 1.68% 23
2024
Q4
$2.96M Buy
3,833
+14
+0.4% +$11.6K 1.51% 28
2024
Q3
$3.38M Sell
3,819
-3,615
-49% -$3.25M 1.69% 23
2024
Q2
$6.73M Sell
7,434
-40
-0.5% -$32K 3.61% 6
2024
Q1
$5.81M Sell
7,474
-180
-2% -$128K 3.18% 6
2023
Q4
$4.46M Sell
7,654
-81
-1% -$47.3K 2.69% 9
2023
Q3
$4.15M Sell
7,735
-152
-2% -$78.3K 2.76% 8
2023
Q2
$3.7M Sell
7,887
-423
-5% -$177K 2.44% 11
2023
Q1
$2.85M Sell
8,310
-151
-2% -$50.9K 1.97% 17
2022
Q4
$3.1M Sell
8,461
-450
-5% -$160K 2.18% 15
2022
Q3
$2.88M Sell
8,911
-748
-8% -$237K 2.23% 13
2022
Q2
$3.13M Sell
9,659
-784
-8% -$235K 2.17% 11
2022
Q1
$2.99M Sell
10,443
-1,852
-15% -$477K 1.8% 19
2021
Q4
$3.4M Sell
12,295
-163
-1% -$41.3K 1.93% 16
2021
Q3
$2.88M Sell
12,458
-502
-4% -$124K 1.81% 17
2021
Q2
$2.98M Sell
12,960
-728
-5% -$146K 1.92% 13
2021
Q1
$2.56M Sell
13,688
-360
-3% -$70.4K 1.98% 15
2020
Q4
$2.37M Buy
+14,048
New +$2.1M 1.87% 15
2019
Q4
$1.98M Sell
15,080
-45
-0.3% -$5.22K 1.84% 19
2019
Q3
$1.69M Sell
15,125
-125
-0.8% -$13.9K 1.72% 23
2019
Q2
$1.69M Sell
15,250
-269
-2% -$31.7K 1.76% 23
2019
Q1
$2.01M Sell
15,519
-290
-2% -$35.3K 2.14% 19
2018
Q4
$1.83M Buy
+15,809
New +$1.77M 2.05% 18

Other funds holding LLY

Signet Investment Advisory Group's LLY Position: Q2 2026 in Review

Signet Investment Advisory Group reduced its Eli Lilly (LLY) stake by 0.64% in Q2 2026, selling an estimated $30.7K and leaving 4,634 shares worth $5.56M. The position accounts for 2.44% of the portfolio, ranked #16.

Signet Investment Advisory Group first reported a position in LLY in Q4 2018 and has held it in 28 quarters since. The position peaked at $6.73M in Q2 2024. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Signet Investment Advisory Group held 4,634 shares of Eli Lilly worth $5.56M as of Q2 2026.
  • Signet Investment Advisory Group sold 30 Eli Lilly shares in Q2 2026, an estimated $30.7K.
  • Eli Lilly made up 2.44% of Signet Investment Advisory Group's portfolio in Q2 2026, its #16 holding.
  • Signet Investment Advisory Group first reported a position in Eli Lilly in Q4 2018 and has held it in 28 quarters since.
  • Signet Investment Advisory Group's Eli Lilly position peaked at $6.73M in Q2 2024.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Signet Investment Advisory Group's 13F filing for Q2 2026, filed 30 Jul 2026.